Effect of CSL112 (apolipoprotein A‐I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross‐study comparison-Reference-Cited by-同舟云学术

Effect of CSL112 (apolipoprotein A‐I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross‐study comparison

Published:2022-08-07 Issue:10 Volume:15 Page:2331-2341
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Zheng Bo¹,Goto Shinya²^ORCID,Clementi Regina¹,Feaster John¹,Duffy Danielle¹,Dalitz Penelope³,Airey Jolanta³,Korjian Serge⁴,Tortorici Michael A.¹,Roberts John¹,Gibson C. Michael⁵

Affiliation:

1. CSL Behring King of Prussia Pennsylvania USA

2. Department of Medicine (Cardiology) Tokai University School of Medicine Isehara Japan

3. CSL Limited Parkville Victoria Australia

4. Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

5. PERFUSE Study Group, Cardiovascular Division, Departments of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

Funder

CSL Behring

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13361

Reference38 articles.

1. Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control

2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

3. Heart Disease and Stroke Statistics—2021 Update

4. EARLY AND LATE RECURRENT CARDIOVASCULAR RISK IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME - META-ANALYSIS AND IMPLICATIONS IN TRIAL DESIGN

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can CSL-112 revolutionize atherosclerosis treatment? A critical look at the evidence;Current Problems in Cardiology;2024-08

2. Anti-inflammation nanomedicine shots through atherosclerotic plaques for targeted treatment and precise diagnosis;Materials & Design;2023-07

3. Clinical Pharmacokinetics and Pharmacodynamics of CSL112;Clinical Pharmacokinetics;2023-03-16